Prevention of fractures is the only way to drastically reduce osteopor
osis-related health expenditures. In order to optimize the cost/benefi
t ratio of a strategy of prevention, it is essential to identify, as e
arly as possible, women who will develop fractures later in their life
. Therefore, and since postmenopausal bone loss is an asymptomatic pro
cess, screening procedures should detect, at the time of the menopause
, women whose postmenopausal bone loss is higher than the mean, and wi
ll, a couple of years later, exhibit a low mineral content and a subse
quent high risk for fractures. For 3 years we have followed a cohort o
f 92 healthy women who had undergone menopause less than 36 months pre
viously. By a multivariate discriminant analysis based on the differen
ces in lumbar bone density, assessed by dual photon absorptiometry, an
d in a few routine biochemical parameters (serum phosphorus, estrone,
androstenedione, and urine calcium) observed during the first 6 months
of the study, we have been able to correctly predict the rate of spin
al bone loss, observed at the end of the 3 years, in 76% of the subjec
ts. All of the women who presented a bone loss higher than 10% over th
e 3 years were correctly isolated by our discriminant functions after
6 months of follow-up. We conclude that a measurement of lumbar bone m
ineral density coupled with a few routine biochemical determinations,
repeated twice at a 6-month interval in healthy postmenopausal women,
can isolate 100% of postmenopausal ''fast bone losers'' with an overal
l specificity of 76%.